Sutter Davis Hospital
Acute Care Hospitals · Voluntary non-profit - Private
2000 Sutter Place
Davis, CA 95616
- Emergency services
- Medicare overall rating: 4 of 5 stars
At a glance
- Clinicians who list this hospital
- 455
- Physicians (MD and DO)
- 414
- Residents and fellows in training (full-time equivalents, fiscal year 2024)
- 5
- Medical groups
- 15+
Quality and patient experience
- Medicare overall rating (of 5)
- 4
- Patient survey rating (of 5)
- 4
- Patients who would definitely recommend it (national average 71%)
- 82%
Compared with the national rate
| Measures | Better | Same | Worse |
|---|---|---|---|
| Deaths after treatment | 0 | 5 | 0 |
| Safety of care (infections, complications) | 1 | 1 | 0 |
| Readmissions and return visits | 1 | 7 | 0 |
Number of Medicare quality measures where this hospital’s rate is statistically better than, the same as (no different from), or worse than the national rate.
What patients said
- Doctors communicated well 4 of 5 stars
- Nurses communicated well 3 of 5 stars
- Explained medicines 4 of 5 stars
- Discharge information 4 of 5 stars
- Clean 4 of 5 stars
- Quiet at night 3 of 5 stars
From 406 patient surveys (HCAHPS), period ending 09/30/2025.
Medicare “birthing-friendly” hospital: takes part in a maternity care quality program and follows recommended safety practices.
Source: CMS Care Compare (Hospital General Information; Patient survey HCAHPS). Ratings describe the hospital overall, not individual doctors.
Physicians by specialty
- Radiology 76
- Family Medicine 55
- Internal Medicine 33
- Cardiology 24
- Anesthesiology 16
- Neurology 14
- Emergency Medicine 14
- Interventional Radiology 13
- Critical Care Medicine 13
- General Surgery 11
- Neuroradiology 11
- Rheumatology 11
- Pathology 11
- Hospitalist 11
- Hematology & Oncology 10
- Urology 9
- Orthopedic Surgery 9
- OB-GYN (Obstetrics & Gynecology) 6
- ENT (Otolaryngology) 6
- Pulmonology 6
- Nephrology (Kidney) 6
- Vascular Surgery 5
- Endocrinology & Diabetes 5
- Gastroenterology 5
- Neurosurgery 4
- Nuclear Medicine 4
- Radiation Oncology 2
- Ophthalmology 2
- Hepatology 2
- Cardiac Electrophysiology 2
- Infectious Disease 2
- Surgical Oncology 1
- Cardiothoracic Surgery 1
- Retina Specialist 1
- Plastic Surgery 1
- Sports Medicine 1
- Physical Medicine & Rehabilitation (PM&R) 1
- Dermatology 1
- Heart Failure & Transplant Cardiology 1
- Geriatric Medicine 1
- Gynecologic Oncology 1
- Hand Surgery 1
- Interventional Cardiology 1
- Obesity Medicine 1
- Spine Surgery 1
- Pain Medicine 1
- Allergy & Immunology 1
Other clinicians
Medical groups whose clinicians work here
- Sutter Valley Medical Foundation 359
- Pulmonary Medicine Associates Medical Group Inc. 20
- Diagnostic PAthology Medical Group Inc 16
- Sacramento Heart and Vascular Medical 3
- Capital Nephrology Medical Group 3
- Central Anesthesia Service Exchange Medical Group Inc 2
- Ong Rubin Shahmir A Medical Corporation 2
- Basso Podiatry Group Inc 2
- Pulmonary Associates Burlingame Medical Corporation 1
- Perlman Center for Eye and Eyelijd Surgery Medical Corp 1
- Metropolitan Anesthesiology Consultants A Medical Group Inc 1
- Rahma Health 1
- Lyon-Martin Community Health Services 1
- Northern California Orthopedic Centers Medical Group 1
- Progressive Anesthesia Consultants of California 1
Number of each group’s clinicians who list this hospital.
Industry-funded research here
Drug and device companies reported $126,298 in research payments to this hospital in 2025 for 12 studies.
- An interventional openlabel randomized multicenter phase 3 study of PF07220060 plus letrozole compared to CDK46 inhibitor plus letrozole in participants over 18 years of age with hormone receptor hrpositive HER2NEGATI…
Pfizer Inc. · $31,534 - NCT03904147--TRILUMINATE Pivotal Trial
Abbott Laboratories · $19,955 - NCT04198870--MitraClip REPAIR MR Study
Abbott Laboratories · $18,871 - Giredestrant CDKi of Choice in ESR1m Enriched 1L HR mBC Secondary Endocrine Resistant Patients
Genentech, Inc. · $16,000 - A Multi Center Observational Registry to Develop Ablation Parameter Guidance for Microwave Liver Ablation of Soft Tissue Lesions
Ethicon Endo-surgery Inc. · $15,550 - The COMPASSHER2 trials comprehensive use of pathologic response assessment to optimize therapy in HER2POSITIVE breast cancer COMPASSHER2 residual disease rd a doubleblinded phase iii randomized trial of TDM1 compared …
Pfizer Inc. · $10,000 - A Phase 2, Randomized, Controlled, Multicenter Study of Vosoritide in Children With Idiopathic Short Stature
BioMarin Pharmaceutical Inc. · $3,999 - NCT06526195--Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Abbott Laboratories · $3,163 - A phase 3 randomized efficacy and safety study of enzalutamide plus leuprolide enzalutamide monotherapy and placebo plus leuprolide in men with highrisk nonmetastatic prostate cancer progressing after definitive therapy
Medivation LLC. · $2,258 - A randomized phase ii trial of salvage radiotherapy with standard vs enhanced androgen deprivation therapy with enzalutamide in patients with postprostatectomy psa recurrences with aggressive disease features
Pfizer Inc. · $2,100 - Pfizer registry of outcomes in growth hormone research progres a multi country noninterventional prospective cohort study among patients with human growth hormone hgh treatments under routine clinical care
Pfizer Inc. · $1,500 - Chemo trastuzumab vs chemo trastuzumab pertuzumab
Genentech, Inc. · $1,368
From CMS Open Payments research payments to this hospital as a teaching hospital. Payments to affiliated universities or research foundations are reported under those names. All industry-funded trials →
Other hospitals in the same county
Sources: CMS Hospital General Information and Doctors and Clinicians Facility Affiliation (Care Compare), CMS certification number 050537. Counts are clinicians who list this hospital with Medicare; they include part-time and visiting clinicians and aren’t staff totals. Residents and beds are from the hospital’s Medicare cost report. Ratings are Medicare’s, not ours.